Unavailability of old antibiotics threatens effective treatment for common bacterial infections

Affiliations

¹ Department of Medical Sciences, Uppsala University, SE 751 85, Uppsala, Sweden.
² Lorraine University, EA 4360 APEMAC, Nancy, France.
³ Global Antibiotic R&D Partnership, Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
⁴ Unit of Infectious Diseases, Hospital Carlos G Durand, Buenos Aires, Argentina.
⁵ British Society for Antimicrobial Chemotherapy, Birmingham, UK.
⁶ Paediatric Infectious Diseases Research Group, St George's University, London, UK.
⁷ Center for Anti-Infective Agents, Vienna, Austria.
⁸ Department of Medical Sciences, Uppsala University, SE 751 85, Uppsala, Sweden. Electronic address: otto.cars@medsci.uu.se.

Thomas Tängdén et al. Lancet Infect Dis. 2018 Mar.

. 2018 Mar;18(3):242-244.

doi: 10.1016/S1473-3099(18)30075-6.

¹ Department of Medical Sciences, Uppsala University, SE 751 85, Uppsala, Sweden.
² Lorraine University, EA 4360 APEMAC, Nancy, France.
³ Global Antibiotic R&D Partnership, Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
⁴ Unit of Infectious Diseases, Hospital Carlos G Durand, Buenos Aires, Argentina.
⁵ British Society for Antimicrobial Chemotherapy, Birmingham, UK.
⁶ Paediatric Infectious Diseases Research Group, St George's University, London, UK.
⁷ Center for Anti-Infective Agents, Vienna, Austria.
⁸ Department of Medical Sciences, Uppsala University, SE 751 85, Uppsala, Sweden. Electronic address: otto.cars@medsci.uu.se.

Erratum in

Corrections.
[No authors listed] [No authors listed] Lancet Infect Dis. 2018 Apr;18(4):376. doi: 10.1016/S1473-3099(18)30173-7. Epub 2018 Feb 28. Lancet Infect Dis. 2018. PMID: 29501279 No abstract available.

No abstract available